Clinical trial

Does Fixing Peripheral Intravenous Catheter With Additional Circular Dressing Material Reduce PIVC Failure And Complications? A Randomized Controlled Trial

Name
EGE-HEM-SL-01
Description
The study was conducted to determine the effect of fixing peripheral intravenous catheter (PIVC) with additional circular dressing material on the duration of PIVC stay and complications related to peripheral intravenous catheterization. In our study, a comparison was made of PIVCs applied to patients in the control (fixation of PIVC with a sterile transparent dressing) and intervention (fixation of PIVC with a sterile transparent dressing and application of an elastane circular dressing on it) groups in a public hospital in Turkey. All-cause PIVC failure was significantly higher in the intervention group (70.2%) compared to the control group (45.5%). It has been determined that fixing the PIVC with additional circular dressing material prolongs the duration of PIVC stay at the site.
Trial arms
Trial start
2023-04-27
Estimated PCD
2023-09-30
Trial end
2023-12-30
Status
Completed
Treatment
intervention group (Elastane circular dressing on sterile transparent dressing)
A circular dressing made of elastane material was placed on the patients in the intervention group on a sterile transparent dressing to provide additional fixation on the peripheral intravenous catheter.
Arms:
Intervention Group (Elastane circular dressing on sterile transparent dressing)
Size
91
Primary endpoint
Skin Penetration Difficulty Rating Scale
four months
Visual Infusion Phlebitis Diagnostic Scale
four months
Infiltration Rating Scale
four months
Data Collection Form for the Patient Who Had a Peripheral Intravenous Catheter
four months
Eligibility criteria
Inclusion criteria * Individuals between the ages of 18-65 * Literate individuals * Individuals who can communicate and fully focus * Individuals without vision, hearing or perception problems Exclusion criteria * Individuals hospitalized for less than 72 hours * Individuals with edema degree 2 and above * Individuals receiving Total Parenteral Nutrition, colloid, blood products * Individuals with a BMI level of 29.9 and above (obese)
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'In our study, a comparison was made of PIVCs applied to patients in the control (fixation of PIVC with a sterile transparent dressing) and intervention (fixation of PIVC with a sterile transparent dressing and application of an elastane circular dressing on it) groups.', 'primaryPurpose': 'SUPPORTIVE_CARE', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 91, 'type': 'ACTUAL'}}
Updated at
2024-03-15

1 organization

1 product

1 indication

Organization
Ege University
Indication
Nurse's Role